Macquarie Group LTD Cytek Biosciences, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$6.69 - $11.99 $3.14 Million - $5.63 Million
-469,708 Reduced 27.25%
1,253,715 $10.7 Million
Q1 2023

May 15, 2023
BUY
$8.44 - $13.47 $5.66 Million - $9.03 Million
670,687 Added 63.71%
1,723,423 $15.8 Million
Q4 2022

Feb 21, 2023
BUY
$9.71 - $15.86 $10.2 Million - $16.7 Million
1,052,736 New
1,052,736 $10.7 Million

Others Institutions Holding CTKB

# of Institutions
134
Shares Held
71.7M
Call Options Held
400
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $851M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email